Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.

Novo Nordisk A/S Nyheter

Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Novo Nordisk A/SBiotech And PharmaceuticalsHealth Care Industry
  • 📰 CNBC
  • ⏱ Reading Time:
  • 27 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 42%
  • Publisher: 72%

Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 a month for the same drug.

The U.S. Senate will investigate the price of Novo Nordisk's popular weight loss and diabetes drugs Ozempic and Wegovy.

The investigation into the Danish drugmaker was announced by Sen. Bernie Sanders, the Vermont Independent who chairs the Health, Education, Labor and Pensions Committee. Sanders also laid out in stark terms the dilemma facing American insurers, including the government, given how high the costs are for the potentially life changing drugs. "If the prices for these products are not substantially reduced they also have the potential to bankrupt Medicare, Medicaid, and our entire health care system," he wrote.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

CNBC /  🏆 12. in US

Novo Nordisk A/S Biotech And Pharmaceuticals Health Care Industry Politics Breaking News: Politics United States Social Issues Business News

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
Les mer »

People Unexpectedly Getting Pregnant on Ozempic and WegovyPeople Unexpectedly Getting Pregnant on Ozempic and WegovyScience and Technology News and Videos
Les mer »

Ozempic, Wegovy not linked to suicide, EU drug regulators sayOzempic, Wegovy not linked to suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions.
Les mer »

No link between Ozempic, Wegovy and suicide, EU drug regulators sayNo link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions.
Les mer »

No link between Ozempic, Wegovy and suicide, EU drug regulators sayNo link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions.
Les mer »

No link between Ozempic, Wegovy and suicide, EU drug regulators sayNo link between Ozempic, Wegovy and suicide, EU drug regulators sayDrug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions.
Les mer »



Render Time: 2025-02-26 19:31:44